ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 21 filers reported holding ESSA PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25 | +13.6% | 8 | 0.0% | 0.00% | – |
| Q2 2023 | $22 | -99.7% | 8 | -99.6% | 0.00% | – |
| Q1 2023 | $6,445 | +152.3% | 2,170 | +114.0% | 0.00% | – |
| Q4 2022 | $2,555 | – | 1,014 | +12575.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 8 | -99.9% | 0.00% | – |
| Q2 2022 | $27,000 | -62.5% | 8,664 | -25.4% | 0.00% | – |
| Q1 2022 | $72,000 | -37.9% | 11,614 | +41.7% | 0.00% | – |
| Q4 2021 | $116,000 | +110.9% | 8,194 | +18.1% | 0.00% | – |
| Q3 2021 | $55,000 | -52.2% | 6,936 | +72.6% | 0.00% | – |
| Q2 2021 | $115,000 | +379.2% | 4,019 | +390.1% | 0.00% | – |
| Q1 2021 | $24,000 | – | 820 | +10150.0% | 0.00% | – |
| Q4 2020 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |